BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23420399)

  • 1. Prodrugs for masking bitter taste of antibacterial drugs--a computational approach.
    Karaman R
    J Mol Model; 2013 Jun; 19(6):2399-412. PubMed ID: 23420399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and in vitro kinetic study of tranexamic acid prodrugs for the treatment of bleeding conditions.
    Karaman R; Ghareeb H; Dajani KK; Scrano L; Hallak H; Abu-Lafi S; Mecca G; Bufo SA
    J Comput Aided Mol Des; 2013 Jul; 27(7):615-35. PubMed ID: 23881217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrugs of acyclovir--a computational approach.
    Karaman R; Dajani KK; Qtait A; Khamis M
    Chem Biol Drug Des; 2012 May; 79(5):819-34. PubMed ID: 22260647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and in vitro kinetics study of atenolol prodrugs for the use in aqueous formulations.
    Karaman R; Qtait A; Dajani KK; Abu Lafi S
    ScientificWorldJournal; 2014; 2014():248651. PubMed ID: 24526887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-assisted design for atenolol prodrugs for the use in aqueous formulations.
    Karaman R; Dajani K; Hallak H
    J Mol Model; 2012 Apr; 18(4):1523-40. PubMed ID: 21785934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-assisted design for paracetamol masking bitter taste prodrugs.
    Hejaz H; Karaman R; Khamis M
    J Mol Model; 2012 Jan; 18(1):103-14. PubMed ID: 21491187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bitterless guaifenesin prodrugs-design, synthesis, characterization, in vitro kinetics, and bitterness studies.
    Thawabteh A; Lelario F; Scrano L; Bufo SA; Nowak S; Behrens M; Di Pizio A; Niv MY; Karaman R
    Chem Biol Drug Des; 2019 Mar; 93(3):262-271. PubMed ID: 30276968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoisomerization kinetics of cefuroxime axetil and related compounds.
    Fabre H; Ibork H; Lerner DA
    J Pharm Sci; 1994 Apr; 83(4):553-8. PubMed ID: 8046613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. Part 1: the influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres.
    Robson HJ; Craig DQ; Deutsch D
    Int J Pharm; 1999 Nov; 190(2):183-92. PubMed ID: 10547458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. III. The use of DSC and HSDSC as means of characterising the interaction of the microspheres with buffered media.
    Robson H; Craig DQ; Deutsch D
    Int J Pharm; 2000 May; 201(2):211-9. PubMed ID: 10878327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. II. The effects of buffer composition on drug release.
    Robson H; Craig DQ; Deutsch D
    Int J Pharm; 2000 Feb; 195(1-2):137-45. PubMed ID: 10675691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric erythromycins: a comparison of the properties of erythromycins A and B 2'-ethyl succinates.
    Hassanzadeh A; Gorry PA; Morris GA; Barber J
    J Med Chem; 2006 Oct; 49(21):6334-42. PubMed ID: 17034139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme Models-From Catalysis to Prodrugs.
    Breijyeh Z; Karaman R
    Molecules; 2021 May; 26(11):. PubMed ID: 34071328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computationally designed prodrugs of statins based on Kirby's enzyme model.
    Karaman R; Amly W; Scrano L; Mecca G; Bufo SA
    J Mol Model; 2013 Sep; 19(9):3969-82. PubMed ID: 23835602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of stable and taste-free erythromycin proprodrugs.
    Bhadra PK; Morris GA; Barber J
    J Med Chem; 2005 Jun; 48(11):3878-84. PubMed ID: 15916440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclization-activated prodrugs: N-(substituted 2-hydroxyphenyl and 2-hydroxypropyl)carbamates based on ring-opened derivatives of active benzoxazolones and oxazolidinones as mutual prodrugs of acetaminophen.
    Vigroux A; Bergon M; Zedde C
    J Med Chem; 1995 Sep; 38(20):3983-94. PubMed ID: 7562932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a microencapsulated form of cefuroxime axetil using pH-sensitive acrylic polymers.
    Lorenzo-Lamosa ML; Cuña M; Vila-Jato JL; Torres D; Alonso MJ
    J Microencapsul; 1997; 14(5):607-16. PubMed ID: 9292436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyloxymethyl as a drug protecting group. Part 7: Tertiary sulfonamidomethyl ester prodrugs of benzylpenicillin: chemical hydrolysis and anti-bacterial activity.
    Iley J; Barroso H; Moreira R; Lopes F; Calheiros T
    Bioorg Med Chem; 2000 Jul; 8(7):1629-36. PubMed ID: 10976510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyloxymethyl as a drug protecting group: Part 4. The hydrolysis of tertiary amidomethyl ester prodrugs of carboxylic acid agents.
    Iley J; Moreira R; Calheiros T; Mendes E
    Pharm Res; 1997 Nov; 14(11):1634-9. PubMed ID: 9434286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Biological Evaluation of Mutual Prodrugs of Carboxylic Group Containing Some Non-Steroidal Anti-Inflammatory Drugs and Propyphenazone.
    Paliwal M; Sucheta ; Ruchita ; Jain S; Monika ; Himanshu
    Curr Drug Deliv; 2017; 14(8):1213-1224. PubMed ID: 28201966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.